AOD-9604 Jump to: Structure | Mechanism | Studies | Pharmacokinetics | Protocols | Limitations | Lead Researcher | References AOD-9604 Peptide Molecular Structure & Chemical Properties AOD-9604 represents a pioneering approach to peptide-based metabolic research, originally developed in the 1990s at Monash University in Australia as a potential anti-obesity therapeutic
Ingredients: BioGlute Complex (proprietary blend of Glutathione and essential phospholipids), olive oil, gelatin, glycerin, calcium carbonate, purified water, yellow beeswax (its natural color)
A laxative effect may occur in case of overdose
External resources Phase 2 trial: Once-weekly cagrilintide for weight management (PubMed) REDEFINE 1: Coadministered cagrilintide and semaglutide in adults with overweight or obesity (NEJM) Development of cagrilintide, a long-acting amylin analogue (Journal of Medicinal Chemistry) For researchers serious about building evidence-based peptide protocols, SeekPeptides offers the most comprehensive resource available
The mechanism is sound: restore GHRH signaling, raise GH and IGF-1, shift fat metabolism toward lipolysis in the visceral depots, and improve downstream metabolic markers